How to treat acute decompensated heart failure in the 'beta-blocker era'?

Eur J Heart Fail. 2010 Aug;12(8):893-4. doi: 10.1093/eurjhf/hfq107.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adrenergic beta-Agonists / administration & dosage
  • Adrenergic beta-Agonists / therapeutic use*
  • Adrenergic beta-Antagonists / administration & dosage
  • Adrenergic beta-Antagonists / therapeutic use*
  • Antihypertensive Agents / administration & dosage
  • Antihypertensive Agents / therapeutic use
  • Cardiotonic Agents / administration & dosage
  • Cardiotonic Agents / therapeutic use*
  • Dobutamine / administration & dosage
  • Dobutamine / therapeutic use*
  • Heart Failure / drug therapy*
  • Humans
  • Hydrazones / administration & dosage
  • Hydrazones / therapeutic use*
  • Pyridazines / administration & dosage
  • Pyridazines / therapeutic use*
  • Simendan
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / therapeutic use

Substances

  • Adrenergic beta-Agonists
  • Adrenergic beta-Antagonists
  • Antihypertensive Agents
  • Cardiotonic Agents
  • Hydrazones
  • Pyridazines
  • Vasodilator Agents
  • Simendan
  • Dobutamine